Law360, New York (May 13, 2010, 7:03 PM ET) -- Aetna Inc. asked a court on Thursday to let it intervene as a class plaintiff on behalf of end payers in the antitrust multidistrict litigation over antidepressant Wellbutrin XL.
If the class is certified as it currently stands — covering only five states — then end payers in every other state “may be forever barred from bringing class claims arising out of the remaining states which permit indirect purchaser suits,” the insurer said in its motion in the U.S. District Court for the Eastern District of...
Aetna Wants To Rep End Payers In Wellbutrin MDL
To view the full article, take a free trial now.
